Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

514

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

514 results for “tumor progression”

Learn how ShareScore rates datasets ↗
geo20/100

Identification of PHLPP1 as a tumor suppressor reveals the role of feedback compensation in PTEN-mutant prostate cancer progression

GEO Series GSE30987. Mus musculus. 8 samples. Type: Expression profiling by array.

openGEO-OpenAug 2011View details →
geo20/100

CBX4 in Lung Adenocarcinoma: A Dual-Edged Sword in Transcriptional Regulation and Tumor Progression [ChIP-Seq]

GEO Series GSE252230. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenJan 2024View details →
geo20/100

Expression data from RCC paired tumors to study metastasis progression

GEO Series GSE23629. Homo sapiens. 32 samples. Type: Expression profiling by array.

openGEO-OpenAug 2010View details →
geo20/100

ALKBH5 promotes tumor progression by decreasing RIG-I expression mediated by N6-methyladenosine-dependent HNRNPC binding in HNSCC [MeRIP-seq]

GEO Series GSE185885. Homo sapiens. 8 samples. Type: Methylation profiling by high throughput sequencing; Expression profiling by high throughput sequencing.

openGEO-OpenApr 2022View details →
geo20/100

Impaired histone inheritance promotes tumor progression

GEO Series GSE201262. Homo sapiens. 126 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing; Other.

openGEO-OpenMay 2023View details →
geo20/100

Endotrophin and CD44-Mediated Heterotypic Signaling Mediates Tumor-Stroma Crosstalk and Facilitates Malignant Progression in Hepatocellular Carcinoma

GEO Series GSE313961. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2026View details →
ClinicalTrials.gov20/100

The Etiology and Progression of Brain Tumors

ClinicalTrials.gov study NCT01811524. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression

ClinicalTrials.gov study NCT01433224. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

ClinicalTrials.gov study NCT03862768. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors

ClinicalTrials.gov study NCT06933524. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression

ClinicalTrials.gov study NCT05779553. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and Progress

ClinicalTrials.gov study NCT01092247. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors

ClinicalTrials.gov study NCT00004080. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Pr

ClinicalTrials.gov study NCT06760676. IPD Sharing: YES. Countries: 0. Publications: 0.

controlledIPD-YESFeb 2026View details →
geo20/100

ALKBH5 promotes tumor progression by decreasing RIG-I expression mediated by N6-methyladenosine-dependent HNRNPC binding in HNSCC

GEO Series GSE185888. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing; Methylation profiling by high throughput sequencing.

openGEO-OpenApr 2022View details →
geo20/100

Altered propionate metabolism contributes to tumor progression and aggressiveness

GEO Series GSE161108. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2022View details →
geo20/100

Arid1a promotes tumor initiation but restrains progression and metastasis in liver cancer [ChIP-Seq]

GEO Series GSE102607. Mus musculus. 18 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenDec 2017View details →
geo20/100

Iron oxide nanoparticles inhibit tumor progression and suppress lung metastases in mouse models of breast cancer [NanoString]

GEO Series GSE261779. Mus musculus. 23 samples. Type: Other.

openGEO-OpenMar 2024View details →
geo20/100

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients

GEO Series GSE19425. Homo sapiens. 532 samples. Type: Genome variation profiling by genome tiling array.

openGEO-OpenDec 2009View details →
geo20/100

NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression

GEO Series GSE272634. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenOct 2024View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record